BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3397256)

  • 1. Role of chemotherapy in acute breast cancer. Analysis of 41 cases.
    Calderoli H; de Manzini N; Keiling R
    Int Surg; 1988; 73(2):112-5. PubMed ID: 3397256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory cancer of the breast. Assessment after 6 years of 16 patients treated by primary immunochemotherapy].
    Zylberberg B; Salat-Baroux J; Ravina JH; Dormont D; Amiel JP; Izrael V; Ekoundzola JR
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(4):515-21. PubMed ID: 3897362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
    Schwartz GF; Meltzer AJ; Lucarelli EA; Cantor JP; Curcillo PG
    J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
    Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous combined radio-/chemotherapy of locally recurring breast cancer].
    Renner H; Lang C; Ziegler K
    Strahlentherapie; 1984 Jul; 160(7):421-4. PubMed ID: 6464045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraclavicular lymph node metastases (SLM) from breast cancer as only site of distant disease: has radiotherapy any role?
    Pergolizzi S; Settineri N; Russi EG; Maisano R; Adamo V; Santacáterina A; Raffaele L; Marchetti G; Mesiti M
    Anticancer Res; 1997; 17(3C):2303-8. PubMed ID: 9216706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of adjuvant chemotherapy for breast cancer in a community practice.
    Rosenberg A; Winer EP; Cadman E
    Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
    J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of adriamycin in the treatment of metastatic breast cancer].
    Dymarskiĭ LIu; Sanchakova AV; Aleksandrova GI; Trishkina EA
    Vopr Onkol; 1984; 30(6):67-73. PubMed ID: 6547554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological analysis of 15 cases with primary breast lymphoma].
    Huang DZ; He XH; Yang S; Shi YK
    Ai Zheng; 2004 Aug; 23(8):939-42. PubMed ID: 15301719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 20. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
    Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS
    J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.